Aytu Bioscience Inc (NASDAQ: AYTU) released some big news yesterday. The company announced that it has presented several poster presentations surrounding MiOXSYS®. Here’s what we saw from the announcement:
AYTU Announces Poster Presentations
As mentioned above, Aytu Bioscience, a company that’s focused on specialty life sciences and focused on the global commercialization of products in the field of urology, announced that it has presented 6 poster presentations. The poster presentations surrounded the clinical potential of MiOXSYS. MiOXSYS is the company’s rapid in vitro diagnostic system designed for qualitative measurement of static oxidation-reduction potential or sORP in human semen. The devise is used as an aid in the diagnosis of infertility in males. In a statement, Josh Disbrow, CEO at AYTU, had the following to offer with regard to the presentations:
“These studies demonstrate the robustness of our MiOXSYS System as a stable and accurate measure of oxidative stress, that can be standardized globally within clinical andrology and IVF laboratories to aid in the assessment of male infertility. MiOXSYS represents an easily accessible, rapid, in-office diagnostic option to measure oxidative stress in semen. Identifying high levels of oxidative stress can help rule in the cause of poor semen quality and lead to intervention strategies associated with the improvement of semen quality and male fertility. Aytu has been committed to conducting research in male infertility with leading centers around the world to continue to validate the ability of MiOXSYS to address this area of high clinical need.”
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
What We’ll Be Watching For Ahead
Moving forward, the CNA Finance team will continue to keep a close eye on AYTU. In particular, we’ll continue to follow the work surrounding MiOXSYS, Fiera and the rest of the company’s robust pipeline. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!